HEADER VIRAL PROTEIN/INHIBITOR 16-APR-23 8J32 TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH TITLE 2 PF00835231 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.L.ZHOU,C.LIN,X.F.ZOU,J.ZHANG,J.LI REVDAT 2 16-OCT-24 8J32 1 REMARK REVDAT 1 17-APR-24 8J32 0 JRNL AUTH X.L.ZHOU,C.LIN,X.F.ZOU,J.ZHANG,J.LI JRNL TITL CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX JRNL TITL 2 WITH PF00835231 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.01 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.357 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 28461 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.842 REMARK 3 FREE R VALUE TEST SET COUNT : 1378 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.0100 - 4.7540 0.97 2851 152 0.1600 0.1791 REMARK 3 2 4.7540 - 3.7739 0.99 2888 126 0.1597 0.1807 REMARK 3 3 3.7739 - 3.2970 0.99 2853 141 0.1986 0.2560 REMARK 3 4 3.2970 - 2.9956 1.00 2850 160 0.2353 0.3063 REMARK 3 5 2.9956 - 2.7810 0.99 2818 154 0.2467 0.3107 REMARK 3 6 2.7810 - 2.6170 0.82 2397 107 0.2505 0.3528 REMARK 3 7 2.6170 - 2.4860 1.00 2859 132 0.2479 0.3055 REMARK 3 8 2.4860 - 2.3778 0.99 2844 141 0.2543 0.3238 REMARK 3 9 2.3778 - 2.2862 0.99 2841 160 0.2770 0.3801 REMARK 3 10 2.2862 - 2.2100 0.66 1882 105 0.3239 0.4143 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.344 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.282 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4644 REMARK 3 ANGLE : 0.973 6333 REMARK 3 CHIRALITY : 0.054 728 REMARK 3 PLANARITY : 0.006 823 REMARK 3 DIHEDRAL : 9.292 2691 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8J32 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-APR-23. REMARK 100 THE DEPOSITION ID IS D_1300036909. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL10U2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28537 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 52.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.21 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.62300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES 7.5, 20% PEG 10000, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.43900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 301 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 5 CG CD CE NZ REMARK 470 ILE A 59 CG1 CG2 CD1 REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 LYS A 137 CG CD CE NZ REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 THR A 175 OG1 CG2 REMARK 470 ARG A 188 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 286 CG CD1 CD2 REMARK 470 PHE A 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 299 CG CD OE1 NE2 REMARK 470 SER B 46 OG REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 LEU B 50 CG CD1 CD2 REMARK 470 LEU B 57 CG CD1 CD2 REMARK 470 LEU B 67 CG CD1 CD2 REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 GLN B 74 CG CD OE1 NE2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 245 CG OD1 OD2 REMARK 470 GLN B 256 CG CD OE1 NE2 REMARK 470 GLU B 270 CG CD OE1 OE2 REMARK 470 ASN B 277 CG OD1 ND2 REMARK 470 ARG B 279 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 286 CG CD1 CD2 REMARK 470 PHE B 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -167.97 -129.50 REMARK 500 ASP A 33 -131.36 56.28 REMARK 500 ASN A 51 72.07 -150.87 REMARK 500 ASN A 84 -117.58 59.52 REMARK 500 PRO A 184 42.98 -88.77 REMARK 500 ASN A 238 38.71 71.57 REMARK 500 ASP B 33 -121.10 53.43 REMARK 500 HIS B 41 2.55 -66.87 REMARK 500 ASN B 51 82.36 -159.53 REMARK 500 ASN B 84 -127.34 54.37 REMARK 500 LEU B 141 -168.38 -106.41 REMARK 500 TYR B 154 74.70 47.47 REMARK 500 ASP B 155 23.99 41.76 REMARK 500 HIS B 164 -34.63 -130.56 REMARK 500 REMARK 500 REMARK: NULL DBREF 8J32 A 3 301 UNP P0DTD1 R1AB_SARS2 3266 3564 DBREF 8J32 B 3 301 UNP P0DTD1 R1AB_SARS2 3266 3564 SEQRES 1 A 299 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 A 299 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 A 299 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 A 299 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN TYR SEQRES 5 A 299 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 A 299 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 A 299 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 A 299 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 A 299 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 A 299 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 A 299 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 A 299 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 A 299 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 A 299 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 A 299 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 A 299 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 A 299 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 A 299 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 A 299 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 A 299 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 A 299 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 A 299 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 A 299 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER SEQRES 1 B 299 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 B 299 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 B 299 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 B 299 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN TYR SEQRES 5 B 299 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 B 299 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 B 299 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 B 299 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 B 299 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 B 299 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 B 299 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 B 299 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 B 299 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 B 299 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 B 299 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 B 299 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 B 299 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 B 299 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 B 299 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 B 299 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 B 299 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 B 299 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 B 299 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER HET V2M A 401 34 HET V2M B 401 34 HETNAM V2M N-[(2S)-1-({(2S,3S)-3,4-DIHYDROXY-1-[(3S)-2- HETNAM 2 V2M OXOPYRROLIDIN-3-YL]BUTAN-2-YL}AMINO)-4-METHYL-1- HETNAM 3 V2M OXOPENTAN-2-YL]-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE HETSYN V2M N-[(2S)-1-({(2S)-4-HYDROXY-3-OXO-1-[(3S)-2- HETSYN 2 V2M OXOPYRROLIDIN-3-YL]BUTAN-2-YL}AMINO)-4-METHYL-1- HETSYN 3 V2M OXOPENTAN-2-YL]-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE, HETSYN 4 V2M BOUND FORM FORMUL 3 V2M 2(C24 H34 N4 O6) FORMUL 5 HOH *25(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 THR A 45 LEU A 50 1 6 HELIX 4 AA4 ASN A 53 LYS A 61 1 9 HELIX 5 AA5 SER A 62 PHE A 66 5 5 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 LYS A 236 1 11 HELIX 8 AA8 THR A 243 LEU A 250 1 8 HELIX 9 AA9 LEU A 250 GLY A 258 1 9 HELIX 10 AB1 ALA A 260 GLY A 275 1 16 HELIX 11 AB2 THR A 292 GLN A 299 1 8 HELIX 12 AB3 SER B 10 GLY B 15 1 6 HELIX 13 AB4 HIS B 41 CYS B 44 5 4 HELIX 14 AB5 THR B 45 LEU B 50 1 6 HELIX 15 AB6 ASN B 53 ARG B 60 1 8 HELIX 16 AB7 SER B 62 HIS B 64 5 3 HELIX 17 AB8 ILE B 200 ASN B 214 1 15 HELIX 18 AB9 THR B 226 TYR B 237 1 12 HELIX 19 AC1 THR B 243 LEU B 250 1 8 HELIX 20 AC2 LEU B 250 GLY B 258 1 9 HELIX 21 AC3 ALA B 260 GLY B 275 1 16 HELIX 22 AC4 THR B 292 SER B 301 1 10 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N GLY B 79 O LYS B 90 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O THR B 175 N MET B 162 LINK SG CYS A 145 C34 V2M A 401 1555 1555 1.86 LINK SG CYS B 145 C34 V2M B 401 1555 1555 1.84 CRYST1 55.167 98.878 58.807 90.00 108.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018127 0.000000 0.005888 0.00000 SCALE2 0.000000 0.010113 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017879 0.00000